Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 21.10% is 29% below its 5-year average of 29.81%, near the low end of its 5-year range (15.18%–48.92%).
24.59% below its 12-month average of 27.98%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 48.92%.
GROSS MARGIN
21.10%
GROSS MARGIN AVG TTM
27.98%
GROSS MARGIN AVG 3Y
23.31%
GROSS MARGIN AVG 5Y
29.81%
GROSS MARGIN AVG 10Y
34.95%
GROSS MARGIN AVG 15Y
37.88%
GROSS MARGIN AVG 20Y
37.51%
CURRENT VS TTM AVG
-24.59%
CURRENT VS 3Y AVG
-9.49%
CURRENT VS 5Y AVG
-29.22%
CURRENT VS 10Y AVG
-39.62%
CURRENT VS 15Y AVG
-44.30%
CURRENT VS 20Y AVG
-43.75%
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
-48.31%
vs the sector median at left
Market Cap
$1.13B
Gross Margin
47.68%
TTM Avg
50.27%
3Y Avg
51.23%
5Y Avg
48.58%
Market Cap
$1.13B
Gross Margin
73.28%
TTM Avg
75.19%
3Y Avg
72.82%
5Y Avg
72.76%
Market Cap
$1.13B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Gross Margin
76.23%
TTM Avg
76.19%
3Y Avg
76.96%
5Y Avg
77.39%
Market Cap
$1.15B
Gross Margin
88.05%
TTM Avg
93.34%
3Y Avg
92.32%
5Y Avg
92.94%
Market Cap
$1.09B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.15B
Gross Margin
99.36%
TTM Avg
84.41%
3Y Avg
76.16%
5Y Avg
77.91%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OPKO Health, Inc. (OPK) | $1.12B | 21.10% | 27.98% | 23.31% | 29.81% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 47.68% | 50.27% | 51.23% | 48.58% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 73.28% | 75.19% | 72.82% | 72.76% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.00% | 0.00% | 0.00% | 0.00% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 76.23% | 76.19% | 76.96% | 77.39% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 88.05% | 93.34% | 92.32% | 92.94% |
| Replimune Group, Inc. (REPL)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| Nektar Therapeutics (NKTR)vs › | $1.15B | 99.36% | 84.41% | 76.16% | 77.91% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 75.86% | 76.84% | 76.91% | 76.44% |
Gross Margin
21.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 48.92% |
| 2026-03-31 | 21.57% |
| 2025-12-31 | 30.29% |
| 2025-09-30 | 20.02% |
| 2025-06-30 | 19.11% |
| 2025-03-31 | 15.18% |
| 2024-12-31 | 46.10% |
| 2024-09-30 | 23.11% |
| 2024-06-30 | 28.35% |
| 2024-03-31 | 24.22% |
| 2023-12-31 | 24.58% |
| 2023-09-30 | 26.70% |
| 2023-06-30 | 47.65% |
| 2023-03-31 | 41.78% |
| 2022-12-31 | 30.21% |
| 2022-09-30 | 17.41% |
| 2022-06-30 | 37.30% |
| 2022-03-31 | 25.92% |
| 2021-12-31 | 27.04% |
| 2021-09-30 | 36.77% |
| 2021-06-30 | 33.79% |
| 2021-03-31 | 33.32% |
| 2020-12-31 | 35.56% |
| 2020-09-30 | 36.28% |
| 2020-06-30 | 46.00% |
| 2020-03-31 | 33.67% |
| 2019-12-31 | 36.58% |
| 2019-09-30 | 37.96% |
| 2019-06-30 | 36.29% |
| 2019-03-31 | 35.28% |
| 2018-12-31 | 32.58% |
| 2018-09-30 | 39.57% |
| 2018-06-30 | 43.09% |
| 2018-03-31 | 39.54% |
| 2017-12-31 | 50.73% |
| 2017-09-30 | 35.95% |
| 2017-06-30 | 44.19% |
| 2017-03-31 | 41.67% |
| 2016-12-31 | 42.18% |
| 2016-09-30 | 49.26% |
| 2016-06-30 | 57.03% |
| 2016-03-31 | 49.31% |
| 2015-12-31 | 48.17% |
| 2015-09-30 | 52.93% |
| 2015-06-30 | 65.98% |
| 2015-03-31 | 65.70% |
| 2014-12-31 | 53.33% |
| 2014-09-30 | 43.76% |
| 2014-06-30 | 46.63% |
| 2014-03-31 | 44.37% |
| 2013-12-31 | 41.77% |
| 2013-09-30 | 42.10% |
| 2013-06-30 | 44.99% |
| 2013-03-31 | 62.53% |
| 2012-12-31 | 45.58% |
| 2012-09-30 | 36.52% |
| 2012-06-30 | 35.81% |
| 2012-03-31 | 43.18% |
| 2011-12-31 | 28.24% |
| 2011-09-30 | 40.99% |
| 2011-06-30 | 41.98% |
| 2011-03-31 | 39.88% |
| 2010-12-31 | 64.99% |
| 2010-09-30 | 30.85% |
| 2010-06-30 | 34.94% |
| 2010-03-31 | 30.22% |
| 2009-12-31 | 25.88% |
| 2009-09-30 | 29.71% |
| 2009-06-30 | 24.84% |
| 2009-03-31 | 32.16% |
| 2008-12-31 | 26.79% |
| 2008-09-30 | 26.69% |
| 2008-06-30 | -16.61% |
| 2008-03-31 | -17.92% |
| 2007-12-31 | 4.60% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 0.00% |
